Dataset from A Randomized, Double Blind, Chronic Dosing (7 Days), Two Period, Six Treatment, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Four Doses of PT003 MDI in Patients With Moderate to Severe COPD, Compared With Its Individual Components (PT005 MDI and PT001 MDI) as Active Controls
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006922
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to demonstrate efficacy of PT003 MDI relative to its
individual components (PT001 MDI and PT005 MDI) in patients with moderate to severe chronic
obstructive pulmonary disease (COPD).
创建时间：
2024-11-26
